Revise Itolizumab phase 3 study protocol for Covid-19: CDSCO panel tells Biocon Medical Dialogues Team13 Sept 2021 5:26 PM ISTNew Delhi: After reviewing Biocon's Phase III trial protocol for Itolizumab for treating Covid-19 patients, the Subject Expert Committee (SEC)...
Pfizer COVID vaccine for kids aged 12, above approved in South Africa Ruchika Sharma13 Sept 2021 3:56 PM ISTJohannesburg: South Africa's health regulator has approved Pfizer's COVID-19 vaccine for use by children aged 12 and older, paving the way for the...
COVID: WHO seeks more data from Sputnik V makers to grant emergency Use Listing Ruchika Sharma13 Sept 2021 1:31 PM ISTNew Delhi: The World Health Organisation has sought some more data from Russia's Gamaleya National Research Institute of Epidemiology and...
How to issue COVID Death Certificate- Govt files guidelines in SC Medical Dialogues Bureau13 Sept 2021 1:30 PM ISTNew Delhi: The Union Government has filed a detailed affidavit before the Supreme Court stating that the Health Ministry and the Indian Council of...
Atleast 2 billion COVID vaccine doses to be available in 2022: Novavax Ruchika Sharma12 Sept 2021 10:30 AM ISTNew Delhi: Vaccine developer Novavax Inc said on Friday at least 2 billion doses of its COVID-19 vaccine would be available in 2022.The company,...
Moderna, Resilience tie up to manufacture mRNA for COVID vaccine Ruchika Sharma12 Sept 2021 10:15 AM ISTCambridge: Moderna, Inc. and National Resilience, Inc. have recently announced an agreement to manufacture drug substance for the Moderna...
Potential danger to public health: Italy on misuse of Parvulan as COVID treatment Ruchika Sharma11 Sept 2021 4:12 PM ISTMilan: Italy's medicines agency AIFA warned on Friday against the misuse of an unlicensed antiviral drug as a COVID-19 therapy, calling it a potential...
EMA lists nerve disorder as side effect of AstraZeneca COVID vaccine MD Bureau11 Sept 2021 10:15 AM ISTAmsterdam: The European health regulatory body has listed Guillain-Barre Syndrome (GBS) -- a neurological disorder -- as a "very rare" side effect of...
Citing feasibility issues, SC rejects door-to-door vaccination plea Farhat Nasim11 Sept 2021 10:15 AM ISTNew Delhi: Refusing to step in further into executive turf, Supreme Court on Wednesday, rejected a PIL seeking door-to-door Covid-19 vaccination drive...
Moderna COVID vaccine superior to Pfizer, JnJ against Delta, claims study MD Bureau11 Sept 2021 9:30 AM ISTNew York: Moderna's vaccine for Covid-19 is significantly more effective against the Delta variant of the SARS-CoV2 virus than Pfizer or Johnson &...
New Covid-19 vaccine tracker to give information on efficacy of jabs Medical Dialogues Bureau11 Sept 2021 9:30 AM ISTThe tracker gives week by week coverage of the first and second doses of vaccines and also their effectiveness.
No efficacy data of Regdanvimab on COVID variants in India: CDSCO panel rejects Abbott proposal Medical Dialogues Team10 Sept 2021 5:41 PM ISTNew Delhi: In a major setback to Abbott Healthcare, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) has...
